List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 1087 studies with search of:   "AstraZeneca" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Terminated Gefitinib in Combination With Chemoradiation in Resectable Gastric Cancer
Condition: Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC
Intervention: Drug: Gefitinib, 5-fluorouracil, leucovorin and radiotherapy
2 Active, not recruiting Prospective Evaluation of Proteinuria and Renal Function in Non-Diabetic Patients With Progressive Renal Disease
Condition: Hyperlipidemia
Interventions: Drug: Rosuvastatin;   Drug: Atorvastatin
3 Completed Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Alternative)
Condition: Congestive Heart Failure
Interventions: Drug: Candesartan;   Drug: Placebo
4 Recruiting Effects of Rosuvastatin on Aortic Stenosis Progression
Condition: Aortic Stenosis
Interventions: Drug: Rosuvastatin;   Drug: Placebo
5 Completed Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia Requiring Mechanical Ventilatory Support
Condition: Pneumonia
Interventions: Drug: MERREM I.V. 2g as a 3 hour infusion every 8 hours;   Drug: vancomycin I.V. 1 g every 12 hours;   Drug: tobramycin I.V. 5 mg/kg every 24 hours;   Drug: MERREM I.V. 1g as a 30 minute infusion every 8 hours;   Drug: MERREM I.V. 500 mg as a 3 hour infusion every 8 hours
6 Completed Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients
Condition: Gastroesophageal Reflux Disease (GERD)
Intervention: Drug: Esomeprazole
7 Completed Chest Pain Pilot Study
Conditions: Chest Pain;   Gastroesophageal Reflux
Intervention: Drug: Esomeprazole
8 Completed Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study
Condition: NSCLC
Intervention: Drug: Gefitinib
9 Completed Esomeprazole in PPI Failures - IMPROVE
Condition: Gastroesophageal Reflux Disease
Interventions: Drug: Esomeprazole;   Drug: Other PPI marketed in Sweden
10 Completed An Open-Label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexium
Condition: Gastric Ulcer
Intervention: Drug: Esomeprazole Sodium
11 Completed A Two-Week Study Assessing the Onset of Effect Questionnaire Administered Pre-Dose Versus Post-Dose in Adult Subjects
Condition: Asthma
Interventions: Drug: Budesonide/formoterol pMDI;   Drug: Budesonide HFA pMDI
12 Recruiting Phase II Study of Best Support Care (BSC) Plus ZD6474 in Patients With Inoperable Hepatocellular Carcinoma (HCC)
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Vandetanib;   Drug: Vandetanib;   Drug: Best Supportive Care
13 Completed Quetiapine Efficacy in Bipolar Depression Study
Condition: Bipolar Depression
Intervention:
14 Recruiting A Canadian Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia
Condition: Schizophrenia
Intervention: Drug: Quetiapine Fumarate Extended- Release
15 Recruiting Phase I Study to Evaluate Bioavailability of Naproxen as PN400 Compared to Naproxen as Proxen S and Naprosyn E
Condition: Healthy Volunteer
Interventions: Drug: PN4000;   Drug: Naproxen (Proxen S);   Drug: Naproxen (Naprosyn E)
16 Completed Arimidex in McCune Albright Syndrome
Condition: McCune-Albright Syndrome
Intervention: Drug: Arimidex 1 mg
17 Completed Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Fulvestrant
18 Active, not recruiting A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
Conditions: Schizoaffective;   Schizophrenic Disorder
Interventions: Drug: quetiapine fumarate;   Drug: risperidone
19 Completed 307B - Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL® in Hypertensive Pediatric Subjects
Condition: Hypertension
Intervention: Drug: metoprolol succinate
20 Completed Examine National Characteristics & Outcome Measures of GERD Patients Using the PPI Acid Suppression Symptom (PASS) Test for Response
Condition: Gastroesophageal Reflux
Intervention: Drug: Esomeprazole

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services